BCL2 and ovarian carcinoma: Based on the results obtained for the BCL2 polymorphism (rs2279115), it can be concluded that the patients with the CC genotype and the C allele (48.98% vs. 39.50%, p = 0.039) showed an increased risk of ovarian cancer.